← All stories
Markets
Bioengineered blood vessel for Coronary Bypass Sustains 18-Month Patency — With a Full Year without Blood Thinners
Nature Communications study reports an off-the-shelf bioengineered coronary conduit that remained patent for 18 months after anticoagulation was withdrawn, advancing a ready-to-use alternative for the hundreds of thousands of patients who u…
Covered by 1 outlet
All coverage · 1 article